Phio Pharmaceuticals Corp reports results for the quarter ended in June - Earnings Summary

Phio Pharmaceuticals

12/08/2021 23:54

* Phio Pharmaceuticals Corp  PHIO.OQ  reported a quarterly
adjusted loss of 20 cents​​ per share for the quarter ended in
June. The lone analyst forecast for the quarter was for a loss
of 26 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Phio Pharmaceuticals Corp's reported EPS for the quarter was a
loss of 20 cents​.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Phio Pharmaceuticals Corp shares had fallen by 19.0% this
quarter and lost 32.0% so far this year.
* The company reported a quarterly loss of $2.69 million.
* Wall Street's median 12-month price target for Phio
Pharmaceuticals Corp is $6.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated August 12 at 10:53 p.m.  ​All
figures in US dollars unless otherwise stated